BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27060763)

  • 1. An evaluation of Minor Groove Binders as anti-Trypanosoma brucei brucei therapeutics.
    Scott FJ; Khalaf AI; Giordani F; Wong PE; Duffy S; Barrett M; Avery VM; Suckling CJ
    Eur J Med Chem; 2016 Jun; 116():116-125. PubMed ID: 27060763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating 5-Nitrothiazoles as Trypanocidal Agents.
    O'Shea IP; Shahed M; Aguilera-Venegas B; Wilkinson SR
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1137-40. PubMed ID: 26596950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitrypanosomal structure-activity-relationship study of synthetic cynaropicrin derivatives.
    Usuki T; Sato M; Hara S; Yoshimoto Y; Kondo R; Zimmermann S; Kaiser M; Brun R; Hamburger M; Adams M
    Bioorg Med Chem Lett; 2014 Feb; 24(3):794-8. PubMed ID: 24433861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 9- and 11-Substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma.
    Maiwald F; Benítez D; Charquero D; Dar MA; Erdmann H; Preu L; Koch O; Hölscher C; Loaëc N; Meijer L; Comini MA; Kunick C
    Eur J Med Chem; 2014 Aug; 83():274-83. PubMed ID: 24973661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
    Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of acyl hydrazide proteinase inhibitors for antiparasitic activity against Trypanosoma brucei.
    Caffrey CR; Schanz M; Nkemngu NJ; Brush M; Hansell E; Cohen FE; Flaherty TM; McKerrow JH; Steverding D
    Int J Antimicrob Agents; 2002 Mar; 19(3):227-31. PubMed ID: 11932146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosol and hydroxytyrosol derivatives as antitrypanosomal and antileishmanial agents.
    Belmonte-Reche E; Martínez-García M; Peñalver P; Gómez-Pérez V; Lucas R; Gamarro F; Pérez-Victoria JM; Morales JC
    Eur J Med Chem; 2016 Aug; 119():132-40. PubMed ID: 27155468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of 1,4-benzodiazepin-2-ones with antitrypanosomal activity.
    Spencer J; Rathnam RP; Harvey AL; Clements CJ; Clark RL; Barrett MP; Wong PE; Male L; Coles SJ; Mackay SP
    Bioorg Med Chem; 2011 Mar; 19(5):1802-15. PubMed ID: 21306904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
    Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
    Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of halo-nitrobenzamides with potential application against human African trypanosomiasis.
    Hwang JY; Smithson D; Connelly M; Maier J; Zhu F; Guy KR
    Bioorg Med Chem Lett; 2010 Jan; 20(1):149-52. PubMed ID: 19963377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
    Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
    Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antitrypanosomal activity of 12 low-molecular-weight antibiotics and observations of structure/activity relationships.
    Iwatsuki M; Otoguro K; Ishiyama A; Namatame M; Nishihara-Tukashima A; Hashida J; Nakashima T; Masuma R; Takahashi Y; Yamada H; Omura S
    J Antibiot (Tokyo); 2010 Oct; 63(10):619-22. PubMed ID: 20717119
    [No Abstract]   [Full Text] [Related]  

  • 14. SAR of 2-amino and 2,4-diamino pyrimidines with in vivo efficacy against Trypanosoma brucei.
    Perales JB; Freeman J; Bacchi CJ; Bowling T; Don R; Gaukel E; Mercer L; Moore JA; Nare B; Nguyen TM; Noe RA; Randolph R; Rewerts C; Wring SA; Yarlett N; Jacobs RT
    Bioorg Med Chem Lett; 2011 May; 21(10):2816-9. PubMed ID: 21507639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Silico Identification and in Vitro Activity of Novel Natural Inhibitors of Trypanosoma brucei Glyceraldehyde-3-phosphate-dehydrogenase.
    Herrmann FC; Lenz M; Jose J; Kaiser M; Brun R; Schmidt TJ
    Molecules; 2015 Sep; 20(9):16154-69. PubMed ID: 26404225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Arylpyrazine-2-carboxamides: A New Core for Trypanosoma brucei Inhibitors.
    Rahmani R; Ban K; Jones AJ; Ferrins L; Ganame D; Sykes ML; Avery VM; White KL; Ryan E; Kaiser M; Charman SA; Baell JB
    J Med Chem; 2015 Sep; 58(17):6753-65. PubMed ID: 26247439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel distamycin analogues that block the cell cycle of African trypanosomes with high selectivity and potency.
    Franco J; Scarone L; Comini MA
    Eur J Med Chem; 2020 Mar; 189():112043. PubMed ID: 31978782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of Trypanosoma brucei active 1-alkyloxy and 1-benzyloxyadamantano 2-guanylhydrazones.
    Papanastasiou I; Tsotinis A; Zoidis G; Kolocouris N; Prathalingam SR; Kelly JM
    ChemMedChem; 2009 Jul; 4(7):1059-62. PubMed ID: 19422003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of 2-(1H-imidazo-2-yl)piperazines series of Trypanosoma brucei growth inhibitors as potential treatment for the second stage of HAT.
    Ciammaichella A; Ferrigno F; Basta A; D'Amico M; Biancofiore I; Nardi V; Ponzi S; Graziani R; Gennari N; Vittoria Orsale M; Fini I; Paonessa G; Summa V; Harper S; Ontoria JM
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127207. PubMed ID: 32354566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors.
    Spinks D; Torrie LS; Thompson S; Harrison JR; Frearson JA; Read KD; Fairlamb AH; Wyatt PG; Gilbert IH
    ChemMedChem; 2012 Jan; 7(1):95-106. PubMed ID: 22162199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.